Induction of V2 receptors in renal medulla of homozygous Brattleboro rats by arginine vasopressin.
Homozygous Brattleboro rats display pronounced diabetes insipidus and when treated continuously with arginine vasopressin (AVP) acquire the ability to produce concentrated urine. In this study, the effects of continual AVP replacement on the pharmacological properties of the renal medullary V2 receptor and coupling to adenylate cyclase were examined. Osmotic minipumps that delivered AVP at four different rates were implanted into male homozygous Brattleboro rats. At the end of the 14 day treatment period, urine osmolalities were 280 +/- 24, 474 +/- 105, 1777 +/- 304 and 2202 +/- 175 mOsm/kg H2O for the 0, 31.25, 62.5 and 125 ng/hr treatment groups, respectively. Plasma AVP levels were below the level of detection for the 0 and 31.25 ng/hr treatment groups, and were 2.5 +/- 0.5 and 6.5 +/- 1.8 pg/ml for the 62.5 and 125 ng/hr treatment groups. Saturation experiments using [3H] AVP and renal medullary membranes revealed binding site concentrations of 57 +/- 9, 84 +/- 23, 164 +/- 17 and 150 +/- 18 fmol/mg protein for the 0, 31.25, 62.5 and 125 ng/hr treatment groups, respectively. AVP-stimulated cyclic AMP accumulation was enhanced in renal medullary membranes prepared from the 62.5 and 125 ng/hr treatment groups when compared to that in the 0 and 31.25 ng/hr treatment groups. From these results, it appears that circulating AVP is necessary for expression of functional V2 receptors in the homozygous Brattleboro rat renal medulla.
Cornett
L E
LE
Department of Physiology and Biophysics, University of Arkansas for Medical Sciences, Little Rock 72205-7199.
Breckinridge
S M
SM
Koike
T I
TI
D000818:Animals; D001127:Arginine Vasopressin / Q000032:analysis / Q000502:physiology*; D002851:Chromatography, High Pressure Liquid; D000242:Cyclic AMP / Q000032:analysis; D003919:Diabetes Insipidus / Q000235:genetics / Q000378:metabolism*; D006720:Homozygote; D007679:Kidney Medulla / Q000378:metabolism*; D008297:Male; D008566:Membranes / Q000378:metabolism; D011863:Radioimmunoassay; D011869:Radioligand Assay; D051381:Rats; D011910:Rats, Brattleboro; D011945:Receptors, Angiotensin / Q000096:biosynthesis*; D017483:Receptors, Vasopressin
D011945:Receptors, Angiotensin; D017483:Receptors, Vasopressin; D001127:Arginine Vasopressin; D000242:Cyclic AMP